Pharmacokinetic changes of M1, M2, M3, and M4 after intravenous administration of a new anthracycline, DA-125, to alloxan-induced diabetes mellitus rats

Research Communications in Molecular Pathology and Pharmacology

Volumn 94, Issue 2, 1996, Pages 181-192

  Choi, Yun J ^a   Lee, Hee J ^a   Kwon, Jong W ^b   Kim, Won B ^b   Yang, J ^b   Lee, Myung G ^a  

^a Seoul National University   (South Korea)

^b Dong A Pharmaceutical Company   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; DRUG METABOLITE; GALARUBICIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG URINE LEVEL; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; LIVER FUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ALLOXAN; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; AREA UNDER CURVE; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DOXORUBICIN; HALF-LIFE; KIDNEY; LIVER; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 0030445843     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Chiou, W.L. (1978). Critical evaluation of potential error in pharmacokinetic studies using the linear trapezoidal rule method for calculation of the area under the plasma level-time curve. J. Pharm. Sci. 67: 539-546.
2. Chiou, W.L. (1979). New calculation method for mean apparent drug volume of distribution and application to rational dosage regimens. J. Pharm. Sci. 68: 1067-1069.
3. Gwilt, P.R., Nahas, R.R. and Tracewell, W.G. (1991). The effects of diabetes mellitus on pharmacokinetics andpharmacodynamics in humans. Clin. Pharmacokinet. 20: 477-490.
4. Kim, S.H., Choi, Y.M. and Lee, M.G. (1993): Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition. J. Pharmacokinet. Biopharm. 21: 1-17.
5. Kim, Y.G., Yoon, E.J., Yoon, W.H., Shim, H.J., Lee, S.D., Kim, W.B., Yang, J. and Lee, M.G. (1996). Pharmacokinetics of DA-125, a new anthracycline, after intravenous administration to uranyl nitrate-induced acute renal failure rats or protein-calorie malnutrition rats. Biopharm. Drug Disposit. 17: 183-195.
6. Lee, S.D., Lee, W.I., Shim, H.J., Lee, E.D., Kim, W.B., Yang, J., Kim, C.-K. and Lee, M. G. (in press). Pharmacokinetics of M1, M2, M3, and M4 after single and multiple intravenous administration of a new anthracycline, DA-125, to rats. New anthracycline analog containing fluorine. J. Clin. Pharm. Ther.
7. Lee, H.J., Paik, W.H. and Lee, M.G. (1995). Pharmacokinetic and tissue distribution changes of adriamycin and adriamycinol after intravenous administration of adriamycin to alloxan-induced diabetes mellitus rats. Res. Commun. Mol. Pathol. Pharmacol. 89: 165-178.
8. Lee, S.D., Park, J.B., Lee, W.I., Shim, H.J., Lee, E.D., Lee, J.J., Kim, W.B., Yang, J., Kim, C.-K. and Lee, M.G. (1995). Pharmacokinetics and antitumor activity of a new anthracycline, DA-125, after intravenous administration to subcutaneously implanted Lewis-lung-carcinoma-bearing mice. Biopharm. Drug Disposit. 16: 489-505.
9. O'Connor, P. and Feely, J. (1987). Clinical pharmacokinetics and endocrine disorders. Therapeutic implications. Clin. Pharmacokinet. 13: 345-364.
10. Park, J.H. (1995). Pharmacokinetic and pharmacodynamic changes of furosemide after intravenous and oral administration to the alloxan-induced diabetes mellitus rats. M. S. Thesis, Seoul National University, Seoul, Korea.
11. Park, K.J., Yoon, W.H., Shin, W.G. and Lee, M.G. (in press). Pharmacokinetic and pharmacodynamic changes of azosemide after intravenous and oral administration of azosemide to alloxan-induced diabetes mellitus rats. J. Pharm. Pharmacol.
12. Shim, H.J., Lee, E.D., Yoon, E.J., Lee, S.D., Kim, W.B., Yang, J. and Lee, M. G. (1994a). Simultaneous determination of a new anthracycline, DA-125, and its metabolites, M1, M2, M3, and M4 in plasma and urine by high-performance liquid chromatography. J. Chromatogra. 565: 407-414.
13. Shim, H.J., Lee, E.D., Yoon, E.J., Lee, S.D., Kim, W.B., Yang, J. and Lee, M. G. (1994b). Pharmacokinetics of FT-ADM after intravenous administration of DA-125, a prodrug of FT-ADM, to rats. A new adriamycin analog containing fluorine. Int. J. Pharm. 103: 147-154.
14. th Edn., Lea & Febiger, Philadelphia, pp 458-467.
15. rd Convention of the Pharmaceutical Society of Korea, Seoul National University, Seoul, Korea, October 21-22, Abstract p 76
16. Yoon, E.J., Lee, W.I., Shim, H.J., Lee, S.D., Kim, W.B., Yang, J. and Lee, M. G. (1996). Adriamycin analogs containing fluorine: Pharmacokinetics of the metabolites (M1, M2, M3, and M4) after intravenous administration of DA-125 or ME2303 to mice and rats. Biopharm. Drug Disposit. 17:373-420.
17. Yoon, E.J., Lee, E.D., Yoon, W.H., Shim, H.J., Lee, S.D., Kim, W.B., Yang, J. and Lee, M.G. (1994). Pharmacokinetics, tissue distribution and biliary excretion of FT-ADM after intravenous administration of DA-125, a prodrug of FT-ADM, to dogs. A new adriamycin analog containing fluorine. Int. J. Pharm. 109: 181-187.